Isoquinolinium,2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-,(1R,1'R,2R,2'R)-, dibenzenesulfonate

CAS : 96946-42-8

Ref. IN-DA00IJVM

Informations sur le produit

• Nom: Isoquinolinium,2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-,(1R,1'R,2R,2'R)-, dibenzenesulfonate
• Synonymes: [u'51W89', u'cisatracurium', u'cisatracurium besilate', u'cisatracurium besylate', u'Nimbex', u'Cisatracurium besylate', u'Nimbex', u'Cisatracurium besilate', u'96946-42-8', u'Cisatracurium (besylate)', u'NIMBEX PRESERVATIVE FREE', u'UNII-80YS8O1MBS', u'80YS8O1MBS', u"Atracurium besylate 1R-cis,1R'-cis form", u'Cisatracurium besylate [USAN]', u'CHEBI:3721', u'51W89', u"(1R-cis,1'R-cis)-Atracurium besylate", u'(1R,2R)-2-(2-Carboxyethyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-veratrylisoquinolinium benzenesulfonate, pentamethylene ester', u'Cisatracurium besilate (INN)', u'Cisatracurium besilate [INN]', u'Cisatracurium besylate (USAN)', u"Isoquinolinium, 2,2'-(1,5-pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, dibenzenesulfonate, (1R-(1alpha,2alpha(1'R(sup *),2'R(sup *))))-", u'Nimbium', u'Nimbex Forte', u'NCGC00017127-01', u'Cisatracurium besylate [USAN:BAN]', u'Cisatracurii besilas', u'Cisatracurium-Kation', u'CAS-64228-81-5', u'Nimbex (TN)', u'Cisatracurium Besylate Preservative Free', u'Besilato de cisatracurio', u'Besilate de cisatracurium', u'AC1L1XZG', u'AC1Q22ND', u'cisatracurium besylate(usan)', u'cisatracurium-besylate-nimbex', u'SCHEMBL40669', u'cisatracurium dibenzenesulfonate', u'Cisatracurium besylate (Nimbex)', u'CHEMBL1200641', u'KS-00000FXO', u'XXZSQOVSEBAPGS-DONVQRBFSA-L', u'HMS3715P04', u'EX-A2646', u's2113', u'AKOS026750111', u'C53H72N2O12.2C6H5O3S', u'CCG-221271', u'CS-2471', u'DB00565', u"(1R,2R,1'R,2'R)-atracurium besylate", u'HY-13596', u'N769', u'C53H72N2O12.2(C6H5O3S)', u'LS-178337', u'TL8006016', u'FT-0657467', u'SW222230-1', u'51 W89', u'D00759', u'W-60404', u'Z2216208615', u'UNII-40AX66P76P component XXZSQOVSEBAPGS-DONVQRBFSA-L', u'UNII-Y78PS7MEDE component XXZSQOVSEBAPGS-DONVQRBFSA-L', u'Cisatracurium besilate, EuropePharmacopoeia (EP) Reference Standard', u'Cisatracurium besylate, United States Pharmacopeia (USP) Reference Standard', u'Cisatracurium for peak identification, EuropePharmacopoeia (EP) Reference Standard', u'Cisatracurium for system suitability, EuropePharmacopoeia (EP) Reference Standard', u"(1R,1'R,2R,2'R)-2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) benzenesulfona", u"(1R,1'R,2R,2'R)-2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) benzenesulfonate", u'(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-2-(3-{[5-({3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-2-yl]propanoyl}oxy)pentyl]oxy}-3-oxopropyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium dibenzenesulfonate', u"(1R,2R,1'R,2'R)-2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate"], (1R,1'R,2R,2'R)-2,2'-[1,5-Pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-isoquinolinium dibenzenesulfonate, (1R,2R)-1-(3,4-dimethoxybenzyl)-2-(3-{[5-({3-[(2R,4R)-4-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-3,4-dihydroisoquinolinium-2(1H)-yl]propanoyl}oxy)pentyl]oxy}-3-oxopropyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium bisbenzenesulfonate, (1R,2R,1'R,2'R)-2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate, 51W89, Cis-Atracurium besilate, Cisatracurium Besilete, Cisatracurium besylate, Isoquinolinium, 2,2′-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,1′R,2R,2′R)-, benzenesulfonate (1:2), Isoquinolinium, 2,2′-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,1′R,2R,2′R)-, dibenzenesulfonate, Isoquinolinium, 2,2′-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, [1R-[1α,2α(1′R*,2′R*)]]-, dibenzenesulfonate, Nimbex, Nimbex (pharmaceutical)
• Marque: Indagoo

Propriétés chimiques

• Masse moléculaire: 1243.4792
• Formule: C₆₅H₈₂N₂O₁₈S₂
• Degré de pureté: 98%
• Couleur/Forme: Solid
• InChI: InChI=1S/C53H72N2O12.2C6H6O3S/c1-54(22-18-38-32-48(62-7)50(64-9)34-40(38)42(54)28-36-14-16-44(58-3)46(30-36)60-5)24-20-52(56)66-26-12-11-13-27-67-53(57)21-25-55(2)23-19-39-33-49(63-8)51(65-10)35-41(39)43(55)29-37-15-17-45(59-4)47(31-37)61-6;2*7-10(8,9)6-4-2-1-3-5-6/h14-17,30-35,42-43H,11-13,18-29H2,1-10H3;2*1-5H,(H,7,8,9)/q+2;;/p-2/t42-,43-,54-,55-;;/m1../s1
• Code InChI: XXZSQOVSEBAPGS-DONVQRBFSA-L